2009 Midyear Clinical Meeting
Click here to go to the previous page
Healthcare Workers Who Handle Hazardous Drugs: Results of Comprehensive Studies of Exposure Risks
Track:
Educational Sessions (CE)
Program Code: 258-L04
Date: Wednesday, December 9, 2009
Time: 8:00 AM to 9:45 AM EST
Location:
3101B - Lido
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Luci Power,
BS, MS, Senior Pharmacy Consultant,
Power Enterprises
Luci Power is an independent consultant and lecturer with Power Enterprises in San Francisco, California. She was a Senior Pharmacist, Manager, at the University of California San Francisco Medical Center for the IV Additive Service and Parenteral Support Service before retiring in 2007. Luci is a recognized expert in the areas of sterile compounding and safe handling of hazardous drugs with numerous presentations and publications in these areas. Luci is the primary author of the 2006 ASHP Guidelines on Handling Hazardous Drugs, lead author of the 1990 ASHP Technical Assistance Bulletin on Handling Hazardous Drugs and a contributing author of the 2004 NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings.
|
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Sami Ahmed,
PharmD, BCPS, Clinical Lead Oncology Pharmacist,
Massachusetts General Hospital
Mr. Ahmed is a member of an interdisciplinary task force established by MGH in 2007 to explore workplace issues related to environmental contamination with hazardous medications. Since its inception the task force has conducted hundreds of environmental surface samples and has identified a model for the path of contamination, beginning w/ receipt of the product and ending w/ the disposal of waste. This is Mr. Ahmed's first formal presentation at ASHP, however he has presented posters at ASHP in the past. Mr. Ahmed will present the findings of the study, thus far.
|
Thomas Connor,
PhD, Research Biologist,
National Institute for Occupational Safety and Health (NIOSH)
Dr. Connor is a Research Biologist at the National Institute for Occupational Safety and Health (NIOSH) in Cincinnati, OH. He was the Project Officer for a study that is examining the potential effects of hazardous drugs on healthcare workers and is also conducting an evaluation of personal protective clothing used in the healthcare industry.
Dr. Connor received his BS and MS in microbiology/chemistry from the University of Rhode Island and his doctorate in environmental toxicology from the University of Texas Medical Branch. He retired from the University of Texas, School of Public Health in Houston, Texas after 20 years as a faculty member in Environmental Sciences and Occupational Health. He was a co-chair of the NIOSH Working Group on Hazardous Drugs. As a member of this working group, he was involved with the writing of a NIOSH Alert on Hazardous Drugs. He was also a member of the Workgroup on Chemotherapy Gloves for the American Society for Testing and Materials as well as the committee to revise the American Society of Health-System Pharmacists safe handling guidelines. Dr. Connor was co-chair of the committee that wrote an international standard for handling antineoplastic agents for the International Society of Oncology Pharmacy Practitioners.
Dr. Connor is a member of the Environmental Mutagen Society, ASHP, ASTM and ISOPP. He is on the editorial board of the Journal of Oncology Pharmacy Practice. He is the recipient of the 2008 ASHP Board of Directors Award. Dr. Connors publications have dealt with occupational exposure to hazardous drugs.
|
Melissa McDiarmid,
MD, MPH, Professor of Medicine and Director, Occupational Health Program,
University of Maryland
Melissa A. McDiarmid, M.D., M.P.H., DABT
Dr. McDiarmid received her B.A. degree in 1975 from the University of Maryland Baltimore County, in Biological Sciences; her M.D. from the University of Maryland at Baltimore in 1979; and her M.P.H. from The Johns Hopkins School of Public Health 1986 where she also completed fellowship training in Occupational Medicine. She is board-certified in Internal Medicine, Occupational Medicine and Toxicology.
Dr. McDiarmid was Director of the Office of Occupational Medicine for the U.S. Occupational Safety & Health Administration (OSHA) in Washington, D.C., a position she held from 1991 until 1996. From 1987 until moving to OSHA, she was Assistant Professor of Environmental Health Sciences at The Johns Hopkins School of Hygiene and Public Health where she directed the Occupational Medicine residency.
A principal career focus for Dr. McDiarmd has been describing the effects from and preventing exposure of healthcare workers to hazardous drugs. While at OSHA she wrote much of its Safe Handing Guidelines for Antineoplastic Drugs and was a member of the NIOSH Alert workgroup on Safe Handling.
Currently, Dr. McDiarmid is Professor of Medicine and Director of the University of Maryland School of Medicines Occupational Health Program where she teaches, sees patients, and directs a surveillance program for Gulf War Veterans exposed to depleted uranium.
|
Luci Power,
BS, MS, Senior Pharmacy Consultant,
Power Enterprises
Luci Power is an independent consultant and lecturer with Power Enterprises in San Francisco, California. She was a Senior Pharmacist, Manager, at the University of California San Francisco Medical Center for the IV Additive Service and Parenteral Support Service before retiring in 2007. Luci is a recognized expert in the areas of sterile compounding and safe handling of hazardous drugs with numerous presentations and publications in these areas. Luci is the primary author of the 2006 ASHP Guidelines on Handling Hazardous Drugs, lead author of the 1990 ASHP Technical Assistance Bulletin on Handling Hazardous Drugs and a contributing author of the 2004 NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings.
|
Description
ACPE Activity #204-000-09-258-L04P / #204-000-09-258-L04T
1.75 Contact Hours / Knowledge-based
Educational Content: General Interest
Moderator: Luci Power, BS, MS, Senior Pharmacy Consultant, Power Enterprises, San Francisco, CA
8:00 a.m. - 8:05 a.m.
Announcements
8:05 a.m. – 8:10 a.m.
"You are IN Jeopardy" Active Learning Module
Luci Power
8:10 a.m. – 8:50 a.m.
NIOSH Study of Healthcare Workers in Three Sites – Study Design and Results
Thomas H. Connor, PhD, Research Biologist, National Institute for Occupational Safety and Health (NIOSH), Cincinnati, OH
8:50 a.m. – 9:10 a.m.
University of Maryland Study of Healthcare Workers – Results
Melissa A. McDiarmid, MD, MPH, Professor of Medicine and Director, Occupational Health Program, University of Maryland, Baltimore
9:10 a.m. – 9:40 a.m.
MGH Study of HD Work Practices Study – Design and Results
Sami Ahmed, PharmD, BCPS, Clinical Lead Oncology Pharmacist, Massachusetts General Hospital, Department of Pharmacy, Boston
9:40 a.m. – 9:45 a.m.
Questions, Answers, and Discussion
Learning Objectives:
- Compare and contrast the results of the studies.
- Identify the concerns of continuing occupational exposure of healthcare workers to hazardous drugs.
- Identify work practices that contribute to exposure and list several improved methods to reduce contamination.